AI Generated
May 9, 2026, 22:55
Romiplostim Versus Placebo in the Management of Chemotherapy-Induced Thrombocytopenia – Transfusion Evidence Library
Transfusion Evidence Library, shared a post on LinkedIn about a recent article by Al-Samkari H et al. published in NEJM, adding:
”New from the Transfusion Evidence Alert:
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.”
Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Authors: Hanny Al-Samkari, César Muñoz, Çağdaş Geredeli, Ioannis Korantzis, Bárbara González Astorga, Can Arslan, João F. Cordeiro Camargo, Franck Scotté , Gilberto Borges, Kai Wang, Martin Kuter, Gerald A. Soff
Stay updated on all scientific advances with Hemostasis Today.
Bárbara González Astorga
Çağdaş Geredeli
Can Arslan
César Muñoz
Franck Scotté
Gerald A. Soff
Gilberto Borges
Hanny Al-Samkari
Health
Hematology
Hemophilia
Hemostasis
Hemostasis News
Hemostasis Today
Ioannis Korantzis
João F. Cordeiro Camargo
Kai Wang
Martin Kuter
Medicine
thrombosis
Transfusion Evidence Library
-
Sep 26, 2026, 14:54Khaled Musallam: TIF Guidelines Advance Emergency Care for Blood-Disorders
-
Sep 26, 2026, 14:47GUMBIT Study Investigating Microbiome Links to ITP – ITP Support Association
-
Sep 26, 2026, 14:41Understanding Recovery After Pulmonary Embolism – ISTH
-
Sep 26, 2026, 14:36Biplab K Saha: Updating the Clinical Approach to IPH
-
Sep 26, 2026, 14:24Andre W. Bourgoyne: Patient Blood Management Before Transfusion
-
Sep 26, 2026, 14:21Damon Race: Transgene Biology and Durability in Hemophilia Gene Therapy
-
Sep 26, 2026, 14:01Chandra Viswanathan: Building a Stronger Blood and Plasma Ecosystem for India
-
Sep 26, 2026, 13:42Dhamirah Nazihah Mohd Nasiruddin: Bridging Clinical Suspicion and Laboratory Diagnosis in TMA
-
Sep 26, 2026, 13:42Anna Dunn: Long-Term Anticoagulation After Pulmonary Embolism